Compares 2-week and 6-week home blood pressure monitoring after childbirth
Tests how long home blood pressure monitoring lasts after delivery in women with pregnancy hypertension.
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Registry title
- HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 7 Jan 2026
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 2-Week Home Monitoring
- 6-Week Home Monitoring
- Record updated
- 14 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 or older who had a hypertensive disorder of pregnancy, gave birth at University of Minnesota Medical Center, and joined the HOPE-BP Program for blood pressure monitoring at home after delivery.
- Age
- 18 years or older
- Sex
- Female
- Disease stage
- Hypertensive disorder of pregnancy; the person has gone home after delivery.
- Earlier treatment
- Must not still be taking blood pressure medicine at 2 weeks after delivery (time of randomization).
Main reasons for not taking part
- Still taking blood pressure medicine at 2 weeks (time of randomization)
- A medical condition that makes it not clinically appropriate to randomize
- Opted out of clinical research
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- 18 years or older
- Discharged after delivery at University of Minnesota Medical Center
- Enrolled into the HOPE-BP Program
Who cannot take part
- Ongoing antihypertensive medication use at 2 weeks (time of randomization)
- Have a medical comorbidity that would not be clinically appropriate to randomize
- Patients opted out of clinical research
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Erin LindenTaking people
About the trial
What the trial wants to find out
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
The 2 groups in the trial
- 2-Week ArmExisting treatment, for comparison
Participants randomized into the 2 week arm will be immediately unenrolled from the postpartum remote blood pressure monitoring program and resume standard postpartum care
Treatment: 2-Week Home Monitoring
- 6-Week ArmExisting treatment, for comparison
Patients randomized into the 6 week arm will continue and complete the program in its entirety per current SOC (4 additional weeks)
Treatment: 6-Week Home Monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
- Plain-language title
- Compares 2-week and 6-week home blood pressure monitoring after childbirthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 January 2026